(Q34295164)

English

Diversity of the juxtamembrane and TKD1 mutations (exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Diversity of the juxtamembrane and TKD1 mutations (exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data (English)

1 reference

Europe PubMed Central

1 August 2017

Torsten Haferlach

6

object named as

Torsten Haferlach

1 reference

Europe PubMed Central

1 August 2017

Tamara Alpermann

4

object named as

Tamara Alpermann

1 reference

Europe PubMed Central

1 August 2017

2

object named as

Ulrike Bacher

1 reference

Europe PubMed Central

1 August 2017

Claudia Haferlach

3

object named as

Claudia Haferlach

1 reference

Europe PubMed Central

1 August 2017

Susanne Schnittger

1

object named as

Susanne Schnittger

1 reference

Europe PubMed Central

1 August 2017

author name string

Wolfgang Kern

5

1 reference

Europe PubMed Central

1 August 2017

publication date

4 June 2012

1 reference

Europe PubMed Central

1 August 2017

Genes, Chromosomes and Cancer

1 reference

Europe PubMed Central

1 August 2017

51

1 reference

Europe PubMed Central

1 August 2017

10

1 reference

Europe PubMed Central

1 August 2017

910-924

1 reference

Europe PubMed Central

1 August 2017

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Structural and numerical variation of FLT3/ITD in pediatric AML.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

21 January 2018

Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2

1 reference

https://api.crossref.org/works/10.1002%2FGCC.21975

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GCC.21975

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34295164&oldid=1545345039"